Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 15.43 | N/A |
| PEG Ratio (TTM) | -0.46 | N/A |
| P/S Ratio (TTM) | 0.89 | N/A |
| P/B Ratio (TTM) | 1.06 | N/A |
| P/FCF Ratio (TTM) | 8.58 | N/A |
| Price to 5YR AVG Earnings Ratio | 7.56 | N/A |
| Price to 5YR AVG FCF Ratio | 9.84 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.50% | N/A |
| ROE (TTM) | 6.98% | N/A |
| Net Profit Margin (TTM) | 5.83% | N/A |
| ROIC 5YR AVG | 19.01% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.14% | 1,037.69% | 639.66% |
| Revenue | -1.46% | 9.49% | 9.54% |
| Net Income | 3.84% | 1,001.95% | 622.31% |
| Cash Flow | 4.87% | 24.50% | 28.48% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.56 | N/A |
| Quick Ratio (TTM) | 0.91 | N/A |
| D/E Ratio (TTM) | 0.42 | N/A |
| Interest Coverage (TTM) | 4.71 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 2.34 | N/A |
| LTL to 5YR AVG FCF | 2.91 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.19% | N/A |